Richard Long

Richard Long

Auto-generated profile, based on publicly available information

Richard Long

Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta , Edmonton, Alberta

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2009 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RLRichard Long
Richard Long
HCHuey Chong
Huey Chong
VHVernon Hoeppner
Vernon Hoeppner
HSHareishun Shanmuganathan
Hareishun Shanmuganathan
KKKinga Kowalewska‐Grochowska
Kinga Kowalewska‐Grochowska
TMThomas Marrie
Thomas Marrie
Background. Fluoroquinolone (FLQ) antibiotics are not uncommonly prescribed for community-acquired pneumonia that is later proven to be pulmonary tub

3 January 2022 in eClinicalMedicine
Verified
Journal Article
Open access
LALeyla Asadi
Leyla Asadi
MCMatthew Croxen
Matthew Croxen
CHCourtney Heffernan
Courtney Heffernan
MDMannat Dhillon
Mannat Dhillon
CPCatherine Paulsen
Catherine Paulsen
RLRichard Long
Richard Long
Sputum smear microscopy is a common surrogate for tuberculosis infectiousness. Previous estimates that smear-negative patients contribute 13–20% of transmissions and are, on average, 20 to 25% as infectious as smear-positive cases are understood to be high. Herein, we use an ideal real-world setting, a comprehensive dataset, and new high-resolution techniques to more accurately estimate the true transmission risk of smear-negative cases. We treated all adult culture-positive pulmonary TB patients diagnosed in the province of Alberta, Canada from 2003 to 2016 as potential transmitters. The primary data sources were the Alberta TB Registry and the Provincial Laboratory for Public Health. We measured, as primary outcomes, the proportion of transmissions attributable to smear-negative sources and the relative transmission rate. First, we replicated previous studies by using molecular (DNA) fingerprint clustering. Then, using a prospectively collected registry of TB contacts, we defined transmission events as active TB amongst identified contacts who either had a 100% DNA fingerprint match to the source case or a clinical diagnosis. We supplemented our analysis with genome sequencing on temporally and geographically linked DNA fingerprint clusters of cases not identified as contacts. There were 1176 cases, 563 smear-negative and 613 smear-positive, and 23,131 contacts. Replicating previous studies, the proportion of transmissions attributable to smear-negative source cases was 16% (95% CI, 12–19%) and the relative transmission rate was 0.19 (95% CI, 0.14–0.26). With our combined approach, the proportion of transmission was 8% (95% CI, 3–14%) and the relative transmission rate became 0.10 (95% CI, 0.05–0.19). When we examined the same outcomes as in previous studies but refined transmission ascertainment with the addition of conventional epidemiology and genomics, we found that smear-negative cases were ∼50% less infectious than previously thought. Alberta Innovates Health Solutions

1 March 2005 in American Journal of Roentgenology
Verified
Journal Article
Closed access
RLRichard Long
Richard Long
EWEric Wong
Eric Wong
JBJames Barrie
James Barrie

9 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJessica Minion
Jessica Minion
VGVictor Gallant
Victor Gallant
JWJoyce Wolfe
Joyce Wolfe
FJFrances Jamieson
Frances Jamieson
RLRichard Long
Richard Long
Nationwide Canadian public health surveillance. Description of demographic features and disease characteristics of drug-resistant tuberculosis (TB) in Canada over a 12 year period. Continuous surveillance of all cases of culture-confirmed TB in Canada. Demographic and microbiologic features were analyzed and comparisons between drug-susceptible, multidrug-resistant (MDR), and drug-resistant not-MDR were made. Cases of extensively drug resistant TB are described. 15,993 cases of culture-confirmed TB were reported during the study period. There were 5 cases of XDR-TB, 177 cases of MDR-TB, and 1,234 cases of first-line drug resistance not-MDR. The majority of drug-resistant cases were reported in foreign-born individuals, with drug-resistant cases diagnosed earlier post-arrival in Canada compared to drug-susceptible cases. In MDR-TB isolates, there was a high rate of drug-resistance to other first- and second-line drugs, making reliable empiric therapeutic recommendations for MDR-TB difficult. There was a statistically significant association between both MDR and drug-resistance not-MDR, and the risk of a negative treatment outcome (defined as treatment failure, absconded, or treatment ongoing >3 yrs). Drug-resistance complicates TB management even in developed nations with well-established TB control programs. The predominantly international origin of drug-resistant cases highlights the need for global strategies to combat TB.

1 March 2005 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
RLRichard Long
Richard Long
RJRichard Jones
Richard Jones
JTJames Talbot
James Talbot
IMIrvin Mayers
Irvin Mayers
JBJames Barrie
James Barrie
BLBruce Light
Bruce Light
Endogenous nitric oxide (NO) has antimycobacterial properties. We tested the hypothesis that exogenous (inhaled) NO can be safely delivered and can accelerate airway disinfection for pulmonary tuberculosis patients treated with standard therapy. Exogenous NO administered at 80 ppm for 72 h can be safely delivered but does not accelerate airway disinfection.

24 March 2011 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
DLD. Langlois-Klassen
D. Langlois-Klassen
KWK.M. Wooldrage
K.M. Wooldrage
JMJ. Manfreda
J. Manfreda
KSK. Sutherland
K. Sutherland
EEE. Ellis
E. Ellis
RLR. Long
R. Long
In major immigrant-receiving countries, annual foreign-born tuberculosis (TB) case counts and rates are relatively constant. Why this is so, and who might be a high-yield target for screening for latent TB infection, remain open questions.Foreign-born TB in Canada during 1986–2002 was retrospectively examined using national TB and immigration data as well as census data. Case counts and rates were analysed in relation to demographics, immigration period and time since arrival.Pre-1986 immigrants (n=3,860,853) and 1986–2002 immigrants (n=3,463,283) contributed 8,662 and 9,613 TB cases, respectively. Immigrants arriving ≤5 yrs ago and those arriving >10 yrs ago contributed almost equally to the annual foreign-born TB case count despite a 3.5-fold difference in in-country person-yrs. Remarkably stable and relatively low TB incidence was observed among immigrants >10 yrs post-arrival. Conversely, TB incidence within 5 yrs of arrival was dynamic, demonstrating a strong inverse association with time since arrival and higher sensitivity to changes in immigration level than shifts toward higher incidence source countries.Relative constancy in foreign-born TB incidence is explained by a complex convergence of several factors. Immigrants born in high-incidence countries who arrived ≤2 yrs ago and were aged 15–34 yrs upon arrival constitute high-yield targets for preventive therapy.